The longevity transporter mIndy (Slc13a5) as a target for treating hepatic steatosis and insulin resistance.

Aging (Albany NY)

Section of Metabolic Vascular Medicine, Medical Clinic III, Dresden University School of Medicine, Technische Universität Dresden, Dresden, Germany.

Published: February 2016

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4789574PMC
http://dx.doi.org/10.18632/aging.100907DOI Listing

Publication Analysis

Top Keywords

longevity transporter
4
transporter mindy
4
mindy slc13a5
4
slc13a5 target
4
target treating
4
treating hepatic
4
hepatic steatosis
4
steatosis insulin
4
insulin resistance
4
longevity
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!